Intersect ENT Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
17,931.00
37,887.00
60,493.00
78,708.00
96,301.00
108,472
Cost of Goods Sold (COGS) incl. D&A
8,150.00
10,223.00
12,288.00
13,003.00
15,499.00
22,613
Gross Income
9,781.00
27,664.00
48,205.00
65,705.00
80,802.00
85,859
SG&A Expense
27,747.00
45,742.00
75,145.00
91,816.00
98,405.00
110,865
EBIT
17,966.00
18,078.00
26,940.00
26,111.00
17,603.00
25,006
Unusual Expense
78.00
-
-
-
-
-
Non Operating Income/Expense
105.00
-
306.00
889.00
1,240.00
2,084
Interest Expense
117.00
409.00
-
-
-
-
Pretax Income
18,369.00
18,362.00
26,634.00
25,222.00
16,363.00
22,922
Consolidated Net Income
18,369.00
18,362.00
26,634.00
25,222.00
16,363.00
22,922
Net Income
18,369.00
18,362.00
26,634.00
25,222.00
16,363.00
22,922
Net Income After Extraordinaries
18,369.00
18,362.00
26,634.00
25,222.00
16,363.00
22,922
Net Income Available to Common
18,369.00
18,362.00
26,634.00
25,222.00
16,363.00
22,922
EPS (Basic)
0.66
1.61
1.02
0.89
0.56
0.76
Basic Shares Outstanding
27,752.30
11,384.00
26,159.00
28,420.00
29,119.00
30,313
EPS (Diluted)
0.66
1.61
1.02
0.89
0.56
0.76
Diluted Shares Outstanding
27,752.30
11,384.00
26,159.00
28,420.00
29,119.00
30,313
EBITDA
17,461.00
17,495.00
26,114.00
24,945.00
16,139.00
23,122
Non-Operating Interest Income
7.00
125.00
-
-
-
-
About Intersect ENT
View Profile
